“We have only one wish at the Institute for Ethnomedicine: to discover new treatments for serious illnesses. This focus has led to the discovery of two promising new drugs for ALS, Alzheimer’s, Parkinson’s and other tangle diseases. We have a third drug in development. Our novel path to discovery has been exciting. Each step of this path, beginning in Guam, has brought us closer to a cure.”
What makes our research approach unique?
Originally conceived on July 4, 2004, Brain Chemistry Labs officially opened its laboratories in June 2006. Patterned after the Miller Research Institute at UC Berkeley and the Institute for Advanced Studies at Princeton, Brain Chemistry Labs is an innovative research organization designed to rapidly discover new cures for serious illnesses.
Brain Chemistry Labs uses a novel model for drug discovery that is significantly different from the traditional pharmaceutical company. Rather than investing in brick and mortar and establishing a large, bureaucratic organization, Brain Chemistry Labs has created a virtual model by inviting world leaders in the appropriate disciplines to perform key components of our research. This collaboration is not only unique, but very efficient and effective in rapidly advancing the research unencumbered by bureaucracy. It incorporates an innovative blend of novel discovery, exceptional human capital, and a singular mission to move from cause to cure.
